Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec 16:15:1219-1222.
doi: 10.2147/CLEP.S434832. eCollection 2023.

Use of the CPRD Aurum Database: Insights Gained from New Data Quality Assessments

Susan Jick  1   2 , Catherine Vasilakis-Scaramozza  1 , Rebecca Persson  1 , David Neasham  3 , George Kafatos  3 , Katrina Wilcox Hagberg  1
Affiliations

Use of the CPRD Aurum Database: Insights Gained from New Data Quality Assessments

Susan Jick et al. Clin Epidemiol. .

Abstract

Ongoing evaluation of any electronic health data source is critical to assess suitability for its use in medical research. In addition, familiarity with a data source's history and recording practices is important for making informed data source selection, study design choices, and interpretation of results. In this commentary, the authors discuss three studies that assessed different aspects of the quality and completeness of information contained in Clinical Practice Research Datalink (CPRD) Aurum compared to the well-established CPRD GOLD and to other linked data sources, with the aim to describe insights gained through these data quality assessments. Our findings support the view that CPRD Aurum and GOLD are both valuable tools for studies based on information recorded in primary care but should not be used without critical consideration of strengths and limitations. Further, use of linked data should be considered for some studies, after taking into account all relevant factors.

Keywords: CPRD Aurum; CPRD GOLD; clinical practice research datalink; data quality; validation.

PubMed Disclaimer

Conflict of interest statement

Kafatos and Neasham are employees of Amgen Ltd, which uses CPRD data, and own shares of Amgen Inc. Jick, Vasilakis-Scaramozza, Persson, and Hagberg are employees of Boston Collaborative Drug Surveillance program which receives industry funding to conduct research using CPRD data. The authors report no other conflicts of interest in this work.

References

    1. Hagberg KW, Vasilakis-Scaramozza C, Persson R, Kafatos G, Neasham D, Jick S. Presence of Breast Cancer Information Recorded in United Kingdom Primary Care Databases: Comparison of CPRD Aurum and CPRD GOLD (Companion Paper 1). Clin Epidemiol. 2023;15:1183–1192. doi:10.2147/CLEP.S434795 - DOI - PMC - PubMed
    1. Vasilakis-Scaramozza C, Hagberg KW, Persson R, et al. Comparison of Rheumatoid Arthritis Information Recorded in UK CPRD Aurum and CPRD GOLD Databases (Companion Paper 3). Clin Epidemiol. 2023;15:1207–1218. doi:10.2147/CLEP.S434831. - DOI - PMC - PubMed
    1. Hagberg KW, Vasilakis-Scaramozza C, Persson R, Neasham D, Kafatos G, Jick S. Correctness and Completeness of Breast Cancer Diagnoses Recorded in UK CPRD Aurum and CPRD GOLD Databases: Comparison to Hospital Episode Statistics and Cancer Registry (Companion Paper 2). Clin Epidemiol. 2023;15:1193–1206. doi:10.2147/CLEP.S434829 - DOI - PMC - PubMed
    1. Jick S, Hagberg KW, Persson R, et al. Quality and completeness of diagnoses recorded in the new CPRD Aurum Database: evaluation of pulmonary embolism. Pharmacoepidemiol Drug Saf. 2020;29(9):1134–1140. doi:10.1002/pds.4996 - DOI - PubMed
    1. Persson R, Sponholtz T, Vasilakis-Scaramozza C, et al. Quality and completeness of myocardial infarction recording in Clinical Practice Research Datalink Aurum. Clin Epidemiol. 2021;13:745–75. 10.2147/CLEP.S319245. - PMC - PubMed